Drug
Beraprost clinical trials
- studies test it
- 11
- open now
- 0
- in phase 3
- 1
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
11 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 2
- Phase 3
- 1
- Phase 4
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 5
Toray Industries, Inc (3) · Astellas Pharma Inc (3) · Dr. Soetomo General Hospital (1) · Shenzhen People's Hospital (1) · The Affiliated Hospital of Xuzhou Medical University (1) · Yonsei University (1) · Seoul National University Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses beraprost is read from its arms, and is right about nine times in ten.
Testing it · 11
- Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMIStatus unknownEarly Phase 1Shenzhen People's HospitalNCT05103813Written as Beraprost Sodium Tablets
- Evaluation of Nail Fold Microcirculation in CKDStatus unknownPhase 4The Affiliated Hospital of Xuzhou Medical UniversityNCT03682952Written as Beraprost sodium tablets
- Effect of Beraprost Sodium (Berasil) on HemodialysisStatus unknownNot applicableYonsei UniversityNCT03142360Written as Beraprost sodium (Berasil)
- Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in ChildrenCompletedPhase 4Dr. Soetomo General HospitalNCT03431649Written as Beraprost Sodium
- Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus PatientsTerminatedPhase 4Astellas Pharma IncNCT02786979Written as Beraprost
- TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)CompletedPhase 2Toray Industries, IncNCT02480751Written as Beraprost
- TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)CompletedPhase 2/3Toray Industries, IncNCT01090037Written as TRK-100STP high dose
- A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal ImpairmentCompletedPhase 1Toray Industries, IncNCT01443429Written as beraprost sodium(BPS)
- Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic NephropathyStatus unknownNot applicableSeoul National University HospitalNCT01796418Written as Beraprost sodium
- Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult MalesCompletedPhase 1Astellas Pharma IncNCT01423435Written as TRK-100STP
- Drug-Drug Interaction Study of TRK-100STPCompletedPhase 1Astellas Pharma IncNCT00719758Written as TRK-100STP (BERASUS LA)
Codes
What other systems call beraprost · ClinicalTrials.gg INT003260
- MeSH (NLM) C048081beraprostConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 35E3NJJ4O6BERAPROSTConfirmed FDA, NLM, Wikidata
- Wikidata Q5977854beraprostConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76896BeraprostOne source FDA
- DrugBank DB05229One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C048081 | beraprost | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 35E3NJJ4O6 | BERAPROST | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5977854 | beraprost | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76896 | Beraprost | One source FDA |
| DrugBank | DB05229 | — | One source Wikidata |
Also registered as beraprost sodium (UNII 15K99VDU5F).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.